Seven femtech innovators shortlisted for Company of the Year award

Seven remarkable femtech innovators have made the shortlist for Femtech World’s Company of the Year award sponsored by Guidea. 

Guidea, a product design agency at the forefront of digital health design, has created transformative solutions through research, design and commercial product launch for top health companies, leading medical schools and pharma companies.

From start-up to enterprise organisation, Guidea’s collaborations aim to consistently deliver meaningful improvements for patient outcomes, raising the standard for digital healthcare.

The shortlisted companies stood out among some truly outstanding entries in one of the most competitive categories.

Congratulations to the shortlist for making the cut and many thanks to all the other submissions for taking the time to enter.

Mira is a San Francisco-based hormonal health company providing integrative care and hormonal testing. The company was founded in late 2015 by a group of scientists, engineers, OB/GYN doctors and business execs to solve the problem of the unavailability of advanced home health testing.

Mira’s mission is to develop data-driven hormonal health solutions to help women make confident health decisions during every stage of their lives – from the menstrual stage to menopause.

Fairtility, an AI innovator in the fertility space, is on a mission to advance reproductive care through the power of transparent AI to help clinicians and their patients on the reproductive care journey.

Its flagship software, CHLOE, is an AI-based decision support tool providing clinicians complete visibility into clinical and laboratory parameters crucial to improving reproductive care outcomes in IVF, fertility preservation and egg donation.

Hertility is a women’s health company on a mission to shape the future of reproductive healthcare by pioneering diagnostic testing that provides data-driven and advanced insights into reproductive health, fertility decline and the onset of menopause.

The company provides expert advice, education and access to care, aiming to reduce the time to diagnosis through advanced at-home testing and specialist gynaecological care.

Flo Health is one of most popular women’s health app globally.

With over 120 medical experts, Flo aims to support women during their entire reproductive lives and provide curated cycle and ovulation tracking, personalised health insights, expert tips and a community for women to share their questions and concerns.

Pregnolia AG is a Swiss medical technology company in the field of preterm birth detection.  The company has developed a measurement device to assess the stiffness of the cervix which serves as a crucial indicator for estimating the risk of preterm birth.

The Pregnolia System is the world’s first patented and CE-marked medical device to measure cervical stiffness. Existing proof-of-concept data confirm that cervical stiffness correlates with earlier births and the diagnostic capabilities are significantly better than the cervical length measured by ultrasound, which is the golden standard in preterm birth diagnosis today.

Hormona is a data-driven women’s health company targeting hormonal imbalances.

Founded in 2020 by Swedish natives Karolina Lofqvist and Jasmine Tagesson, Hormona is the developer behind an at-home urine test that measures the three most important female hormones quantitatively in less than 15 minutes, removing the need for a lab and helping women monitor their hormone levels from the comfort of their homes.

Through regular testing, the company aims to support women with issues, such as irregular cycles, hormonal imbalance, PCOS, perimenopause, menopause and infertility, and help them live in harmony with their hormones.